Long QT syndrome type 2 (LQT2) isan inherited disease leading to arrhythmiasandsudden deathoften in response to an abruptsympatheticstimulus. Heart period (HP) and QT interval variability analyses were carried out overasymptomatic (ASYMP, n=10, age 39.0±11.0yrs, 9 males) and symptomatic (SYMP, n=7, age 41.7±12.8yrs, 4 males) LQT2patients. Beat-to-beat series were derived from 24h Holter ECGrecordingsduring daytime and nighttime. In addition to HP and QT mean and variance,wecalculated HP power in high frequency (HF, from 0.15 to 0.5 Hz) band as a marker of vagal modulation directed to sinus node and QT power in low frequency(LF, from 0.04 to 0.15 Hz)bandas a marker ofsympathetic modulation directed to ventricles.HP and QT means exhibited significant day-night changesin both groups. ASYMP showeda shorter corrected QT anda more reactive vagalmodulationleading to significant day-night variations of respiratory sinus arrhythmia. By contrast, SYMP had no significant day-night variations of the vagalcontrol. Conversely, SYMP showed a higher sympathetic control during day compared to ASYMP,havingalarger QT variance. These findings suggest that frequency domain HP and QT variability markers can account for the different arrhythmic risk of LQT2 ASYMP and SYMP patients.

Frequency domain heart period and QT interval variability markers are linked to arrhythmic risk in long QT syndrome type 2 / V. Bari, G. Girardengo, B. De Maria, B. Cairo, L. Crotti, P.J. Schwartz, A. Porta. - In: COMPUTING IN CARDIOLOGY. - ISSN 2325-887X. - 47(2020). ((Intervento presentato al 47. convegno Computing in Cardiology 2020 tenutosi a Rimini, Italy nel 2020.

Frequency domain heart period and QT interval variability markers are linked to arrhythmic risk in long QT syndrome type 2

V. Bari
Primo
;
B. Cairo;A. Porta
Ultimo
2020

Abstract

Long QT syndrome type 2 (LQT2) isan inherited disease leading to arrhythmiasandsudden deathoften in response to an abruptsympatheticstimulus. Heart period (HP) and QT interval variability analyses were carried out overasymptomatic (ASYMP, n=10, age 39.0±11.0yrs, 9 males) and symptomatic (SYMP, n=7, age 41.7±12.8yrs, 4 males) LQT2patients. Beat-to-beat series were derived from 24h Holter ECGrecordingsduring daytime and nighttime. In addition to HP and QT mean and variance,wecalculated HP power in high frequency (HF, from 0.15 to 0.5 Hz) band as a marker of vagal modulation directed to sinus node and QT power in low frequency(LF, from 0.04 to 0.15 Hz)bandas a marker ofsympathetic modulation directed to ventricles.HP and QT means exhibited significant day-night changesin both groups. ASYMP showeda shorter corrected QT anda more reactive vagalmodulationleading to significant day-night variations of respiratory sinus arrhythmia. By contrast, SYMP had no significant day-night variations of the vagalcontrol. Conversely, SYMP showed a higher sympathetic control during day compared to ASYMP,havingalarger QT variance. These findings suggest that frequency domain HP and QT variability markers can account for the different arrhythmic risk of LQT2 ASYMP and SYMP patients.
Settore ING-INF/06 - Bioingegneria Elettronica e Informatica
Article (author)
File in questo prodotto:
File Dimensione Formato  
Bari_CinC_2020.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 568.52 kB
Formato Adobe PDF
568.52 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/807274
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact